Chester County News and Community Website
Neuronetics, Inc. (NASDAQ: STIM), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) recently announced the issuance of Restricted Stock Units (RSUs) as part of inducement awards granted to two newly hired non-executive employees. The awards cover …
Neuronetics Announces Stock Awards to New Employees Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) today announced the pricing of its underwritten public offering of 8,000,000 shares of common stock at $2.25 per share. The offering is expected …
Neuronetics Prices Public Offering of Common Stock at $2.25 Per Share Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has shared its preliminary fourth quarter and full-year revenue figures for 2024, alongside robust guidance and strategic priorities for 2025. The report highlights …
Neuronetics Reports 2024 Revenue Growth, Reveals Optimistic 2025 Guidance Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has granted performance restricted stock units (PRSUs) to Bill Leonard as part of an inducement award tied to his employment with the company. The …
Neuronetics Awards Stock Units to New Employee Bill Leonard Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced its participation in the esteemed Piper Sandler 36th Annual Healthcare Conference!
Neuronetics to Showcase Neurohealth Innovations at Piper Sandler Healthcare Conference! Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has announced the issuance of inducement awards in the form of Restricted Stock Units (RSUs) to seven newly appointed non-executive employees. This strategic …
Neuronetics Grants Inducement Awards to New Employees Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has reported its financial and operational results for the third quarter of 2024, amid significant developments including the approval of its acquisition of …
Neuronetics Announces Q3 2024 Financial Results and Greenbrook TMS Acquisition Approval Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) this week announced significant progress in expanding access to its NeuroStar TMS Therapy for patients with major depressive disorder (MDD).
Neuronetics Expands TMS Coverage, Enhancing Access for MDD Treatment Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has announced significant enhancements to its NeuroStar Advanced Therapy and TrakStar® software, aiming to improve patient care and strengthen data management. These updates introduce …
Neuronetics Enhances NeuroStar Therapy with New Features Read More
MALVERN, PA — In recognition of Suicide Prevention Month, Neuronetics, Inc. (NASDAQ: STIM) is spotlighting the impactful stories shared on its NeuroStar Voices Portal. This platform, launched last year, allows individuals …
Neuronetics’ Breakthrough: How NeuroStar Therapy Is Transforming Lives Amid Rising Suicide Rates Read More